https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-10 / Pathol Oncol Res 2021;27:1610048
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-10 / Pathol Oncol Res 2021;27:16100482021-12-10 00:00:002021-12-10 00:00:00Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-10712021-11-24 00:00:002021-11-24 00:00:00Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-03 / Diseases 2021 Nov;9(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-03 / Diseases 2021 Nov;9(4)2021-11-03 00:00:002023-01-31 15:56:49Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients-A Single-Center Case-Control Study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-16 / Eur J Cancer 2021 Oct;158:123-132
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-16 / Eur J Cancer 2021 Oct;158:123-1322021-10-16 00:00:002021-10-16 00:00:00Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-21 / Exp Ther Med 2021 Jul;22(1):787
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-21 / Exp Ther Med 2021 Jul;22(1):7872021-05-21 00:00:002023-01-31 15:58:28Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)2021-04-06 00:00:002021-04-06 00:00:00Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-17 / Mol Clin Oncol 2021 May;14(5):103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-17 / Mol Clin Oncol 2021 May;14(5):1032021-03-17 00:00:002023-01-31 15:58:55Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-13 / J Neurooncol 2021 May;152(3):419-428
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-13 / J Neurooncol 2021 May;152(3):419-4282021-03-13 00:00:002021-03-13 00:00:00Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-13 / Cancers (Basel) 2021 Mar;13(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-13 / Cancers (Basel) 2021 Mar;13(6)2021-03-13 00:00:002021-03-13 00:00:00Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)2021-03-12 00:00:002021-03-12 00:00:00Hyperthermia-Based Anti-Cancer Treatments
